Sangam Healthcare Q2 FY26 Net Profit at ₹3.53 Crore

Net Sales/Income from Operations: Not separately quantified (included in total income)
Other Income: ₹3385 (appears to be data error, likely ₹3.85 lakhs based on context)
Total Income: ₹313.85 lakhs
Total Expenses: ₹264.57 lakhs
Profit from Operations before Extraordinary Items: ₹19.28 lakhs
Current Tax: ₹12.81 lakhs
Deferred Tax: ₹1.22 lakhs
Net Profit After Tax: ₹35.25 lakhs
Basic and Diluted EPS: ₹0.24 (not annualized)

Total Assets: ₹1,193.73 lakhs
Non-Current Assets: ₹577.70 lakhs (including Property, Plant & Equipment: ₹27.29 lakhs)
Current Assets: ₹616.03 lakhs (including Inventories: ₹88.28 lakhs, Trade Receivables: ₹404.01 lakhs)
Equity Share Capital: ₹1,486.07 lakhs (14,860,700 shares of ₹10 face value)
Other Equity: Negative ₹3,405.14 lakhs
Total Equity: Negative ₹1,919.07 lakhs
Non-Current Liabilities: ₹2,335.06 lakhs (including Borrowings: ₹2,172.09 lakhs)
Current Liabilities: ₹777.74 lakhs

Cash from Operating Activities: ₹21.81 lakhs
Cash from Investing Activities: ₹0.00 lakhs
Cash from Financing Activities: Negative ₹21.30 lakhs (mainly repayment of borrowings: ₹21.25 lakhs)
Net Increase in Cash: ₹0.51 lakhs
Cash and Cash Equivalents at End: ₹15.68 lakhs

Date: November 13, 2026
Time: 5:30 PM to 6:50 PM IST
Location: Registered office of the Company
Agenda Items Approved: Un-audited financial results for quarter and half year ended September 30, 2026, and limited review report

Auditor Firm: M M Reddy & Co., Chartered Accountants (Firm Reg No.: 010371)
Review Standard: Standard on Review Engagement (SRE) 2410
Conclusion: No material misstatements found in the financial results prepared in accordance with Ind AS 34
Date of Report: November 13, 2026